Cardiff Oncology, Inc. (CRDF) — Net Income

Annual figures by fiscal year, from SEC filings.

2001: -$267.6K2002: -$524.2K2003: -$481.6K2004: -$383.0K2005: -$5.37M2006: -$7.84M2007: -$7.13M2008: -$5.17M2009: -$2.48M2010: -$5.45M2011: -$2.24M2012: -$11.57M2013: -$11.81M2014: -$14.33M2015: -$27.47M2016: -$39.20M2017: -$24.91M2018: -$16.46M2019: -$16.41M2020: -$19.31M2021: -$28.29M2022: -$38.70M2023: -$41.44M2024: -$45.43M2025: -$45.85M-$45.85M
2001Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$45.85M-0.9%
2024-$45.43M-9.6%
2023-$41.44M-7.1%
2022-$38.70M-36.8%
2021-$28.29M-46.5%
2020-$19.31M-17.6%
2019-$16.41M+0.3%
2018-$16.46M+33.9%
2017-$24.91M+36.5%
2016-$39.20M-42.7%
2015-$27.47M-91.8%
2014-$14.33M-21.3%
2013-$11.81M-2.1%
2012-$11.57M-416.5%
2011-$2.24M+58.9%
2010-$5.45M-119.4%
2009-$2.48M+51.9%
2008-$5.17M+27.6%
2007-$7.13M+9.1%
2006-$7.84M-46.0%
2005-$5.37M-1302.3%
2004-$383.0K+20.5%
2003-$481.6K+8.1%
2002-$524.2K-95.9%
2001-$267.6K